I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy (RISIRLC)
Safety and Efficacy of 3D-printing Template Assisted CT-guided Radioactive I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After External Beam Radiotherapy: a Multicenter, Prospective Cohort Study
Sponsor: Peking University Third Hospital
A observational or N/A phase clinical study on Brachytherapy and Non-small Cell Lung Cancer, this trial is actively recruiting participants. The trial is conducted by Peking University Third Hospital and has accumulated 9 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Jul 2022 — Jan 2024 [monthly]
Recruiting
-
Jun 2021 — Jul 2022 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2020 — Jul 2020 [monthly]
Not Yet Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University Third Hospital
For direct contact, visit the study record on ClinicalTrials.gov .